OSUCCC – James Cancer Diagnostic Center speeds up diagnosis, treatment

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A new center at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute gives patients direct, expedited access to diagnostic testing for cancer.

The center’s goal is to provide immediate community-wide patient access to cancer providers for anyone with a suspected cancer, especially in communities where access to healthcare is limited and has become more challenging during the COVID-19 pandemic.

The James Cancer Diagnostic Center offers a platform for expert evaluation and access to the appropriate diagnostic testing so that a cancer diagnosis can be made in a timely and precise manner, in a low-risk environment. Center visits can be virtual or in-person based on the patient’s preference.

Launched on June 15, the Cancer Diagnostic Center is open daily and staffed by a team of advanced practice professionals and nurses who have expertise in oncology. The team is overseen by physicians with oncology experience and expertise.

The center is available for both self- or physician-referral. Center staff first identify and prioritize patient needs and concerns and then coordinate appropriate testing and evaluation on behalf of the patient at facilities within The James and the Ohio State Wexner Medical Center. Follow-up care is also coordinated with a specialized, multidisciplinary team at The James if a cancer diagnosis is made.

Table of Contents

YOU MAY BE INTERESTED IN

Just consider for a minute if this was the first year of running your lab, if you were on the job market as a physician or scientist right now, if you were a resident contemplating a career in cancer research after fellowship, if you were a graduate student or postdoc, if you were an undergraduate or a technician who was looking toward graduate school.
The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadly, a majority of patients with advanced solid tumors still succumb to their disease. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login